Medications approved by United States Food and Drug Administration for tobacco cessation coverage

(a) The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation: (1) Nicotine replacement therapy patches; (2) Nicotine replacement therapy gum; (3) Nicotine replacement therapy lozenges; (4) Nicotine replacement therapy nasal spray; (5) Nicotine replacement therapy inhalers; (6) Bupropion; and (7) Varenicline. (b) Prior authorization shall not be required for coverage of medications described in subsection (a) of this section. Added by Act 2019, No. 959,§ 2, eff. 7/24/2019. (a) The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation: (1) Nicotine replacement therapy patches; (2) Nicotine replacement therapy gum; (3) Nicotine replacement therapy lozenges; (4) Nicotine replacement therapy nasal spray; (5) Nicotine replacement therapy inhalers; (6) Bupropion; and (7) Varenicline. (1) Nicotine replacement therapy patches; (2) Nicotine replacement therapy gum; (3) Nicotine replacement therapy lozenges; (4) Nicotine replacement therapy nasal spray; (5) Nicotine replacement therapy inhalers; (6) Bupropion; and (7) Varenicline. (b) Prior authorization shall not be required for coverage of medications described in subsection (a) of this section. Added by Act 2019, No. 959,§ 2, eff. 7/24/2019.